Impact of Disrupted Botulinum Toxin Therapy in Movement Disorders Due to COVID-19 Pandemic.
作者信息
Neeraja Koti, Surisetti Bharath Kumar, Mol Nisha, Prasad Shweta, Holla Vikram Venkappayya, Kamble Nitish, Mahale Rohan, Pal Pramod Kumar, Yadav Ravi
机构信息
Department of Neurology, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India.
Department of Clinical Neurosciences, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India.
出版信息
Ann Indian Acad Neurol. 2021 Nov-Dec;24(6):1001-1002. doi: 10.4103/aian.AIAN_573_20. Epub 2020 Sep 2.
Abstract
摘要
相似文献
1
Impact of Disrupted Botulinum Toxin Therapy in Movement Disorders Due to COVID-19 Pandemic.新冠疫情导致肉毒毒素治疗中断对运动障碍的影响
Ann Indian Acad Neurol. 2021 Nov-Dec;24(6):1001-1002. doi: 10.4103/aian.AIAN_573_20. Epub 2020 Sep 2.
2
Botulinum Toxin Services for Neurorehabiliation: Recommendations for Challenges and Opportunities during the COVID-19 Pandemic.肉毒毒素在神经康复中的应用：COVID-19 大流行期间的挑战与机遇建议。
Toxins (Basel). 2021 Aug 22;13(8):584. doi: 10.3390/toxins13080584.
3
Botulinum toxin B treatment in children with spastic movement disorders: a pilot study.肉毒杆菌毒素B治疗儿童痉挛性运动障碍：一项初步研究。
Pediatr Neurol. 2004 Aug;31(2):109-13. doi: 10.1016/j.pediatrneurol.2003.12.016.
4
Office-based endoscopic botulinum toxin injection in laryngeal movement disorders.基于诊室的内镜下肉毒毒素注射治疗喉部运动障碍。
Eur Ann Otorhinolaryngol Head Neck Dis. 2018 Jun;135(3):205-207. doi: 10.1016/j.anorl.2018.01.007. Epub 2018 Apr 13.
5
Botulinum toxin for the treatment of movement disorders.肉毒毒素治疗运动障碍。
Curr Neurol Neurosci Rep. 2012 Aug;12(4):399-409. doi: 10.1007/s11910-012-0286-3.
6
Guidelines for the therapeutic use of botulinum toxin in movement disorders. Italian Study Group for Movement Disorders, Italian Society of Neurology.肉毒杆菌毒素在运动障碍治疗中的应用指南。意大利运动障碍研究小组，意大利神经病学会。
Ital J Neurol Sci. 1997 Oct;18(5):261-9. doi: 10.1007/BF02083302.
7
Impact of the botulinum-A toxin on prevention of adult migraine disorders.肉毒杆菌A毒素对预防成人偏头痛疾病的影响。
J Integr Neurosci. 2020 Mar 30;19(1):201-208. doi: 10.31083/j.jin.2020.01.1240.
8
Use of botulinum toxin for movement disorders.肉毒杆菌毒素在运动障碍中的应用。
Drugs Context. 2019 Jun 18;8:212586. doi: 10.7573/dic.212586. eCollection 2019.
9
Review article: botulinum toxin in the therapy of gastrointestinal motility disorders.综述文章：肉毒杆菌毒素在胃肠动力障碍治疗中的应用
Aliment Pharmacol Ther. 2003 Jul 1;18(1):1-16. doi: 10.1046/j.1365-2036.2003.01598.x.
10
COVID-19-related delays of botulinum toxin injections have a negative impact on the quality of life of patients with dystonia and spasticity: a single-center ambulatory care study.新冠疫情导致肉毒毒素注射延迟，对肌张力障碍和痉挛患者的生活质量产生负面影响：一项单中心门诊护理研究。
J Neural Transm (Vienna). 2022 Jan;129(1):49-53. doi: 10.1007/s00702-021-02430-z. Epub 2021 Oct 23.
本文引用的文献
1
Medication management and adherence during the COVID-19 pandemic: Perspectives and experiences from low-and middle-income countries.新冠疫情期间的药物管理和依从性：来自中低收入国家的观点和经验。
Res Social Adm Pharm. 2021 Jan;17(1):2023-2026. doi: 10.1016/j.sapharm.2020.04.007. Epub 2020 Apr 15.
2
Movement Disorders in the World of COVID-19.新冠疫情下的运动障碍
Mov Disord. 2020 May;35(5):709-710. doi: 10.1002/mds.28069. Epub 2020 Apr 16.
3
Clinical Practice: Evidence-Based Recommendations for the Treatment of Cervical Dystonia with Botulinum Toxin.临床实践：肉毒杆菌毒素治疗颈部肌张力障碍的循证推荐
Front Neurol. 2017 Feb 24;8:35. doi: 10.3389/fneur.2017.00035. eCollection 2017.
4
Pain perception in idiopathic cervical dystonia (spasmodic torticollis).特发性颈部肌张力障碍（痉挛性斜颈）中的疼痛感知。
Pain. 1996 Oct;67(2-3):483-91. doi: 10.1016/0304-3959(96)03153-3.
Zotero 插件